(Q38379218)

2 September 2017

title

MethotrexaTE THerapy in ST-Segment Elevation MYocardial InfarctionS. (English)

1 reference

2 September 2017

main subject

myocardial infarction

1 reference

1 reference

Daniel Medeiros Moreira

1

1 reference

2 September 2017

Maria Emilia Lueneberg

2

1 reference

2 September 2017

Roberto Leo da Silva

3

1 reference

2 September 2017

Tammuz Fattah

4

1 reference

2 September 2017

Carlos Antonio Mascia Gottschall

5

1 reference

2 September 2017

publication date

1 January 2017

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

2 September 2017

published in

1 reference

2 September 2017

page(s)

1074248417699884

1 reference

Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Methotrexate modulates the kinetics of adenosine in humans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Impact of Intracoronary Adenosine on Myonecrosis in Patients with Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: a randomized double-blind, placebo-controlled trial (METIS trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Rationale and design of the TETHYS trial: the effects of methotrexate therapy on myocardial infarction with ST-segment elevation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Yerba Mate Tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Assessment of adenosine-induced coronary steal in the setting of coronary occlusion based on the extent of opacification defects by myocardial contrast echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Early expression of angiogenesis factors in acute myocardial ischemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Post-infarct remodelling: contribution of wound healing and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Macrophages are required for neonatal heart regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248417699884

21 January 2018

Identifiers

DOI

10.1177/1074248417699884

1 reference

2 September 2017

1 reference